Our technology gives failed drug molecules a second chance.

Press Releases

10.12.2018 Nanoform continues rapid expansion with construction of GMP manufacturing plant

PRESS RELEASE 10 December 2018 Nanoform continues rapid expansion with construction of GMP manufacturing plant Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced the construction of a GMP manufacturing plant to provide API ‘solution to particle’ nanonization for clinical trials. A nine-year contract has been signed to build the 600m2 facility …

10.12.2018 Nanoform continues rapid expansion with construction of GMP manufacturing plantRead More »

29.10.2018 Nanoform set to globalize its technology with appointment of a Chief Commercial Officer

PRESS RELEASE 29 October 2018 Nanoform set to globalize its technology with appointment of a Chief Commercial Officer Helsinki, Finland – Nanoform, a Helsinki, Finland-based drug particle engineering and nanotechnology company, is set to globalize its novel nanonization technology with the appointment of Christian Jones as Chief Commercial Officer. The newly created role is imperative …

29.10.2018 Nanoform set to globalize its technology with appointment of a Chief Commercial OfficerRead More »

19.09.2018 Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology

PRESS RELEASE 19 September 2018 Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology Helsinki, Finland – Nanoform, an innovative drug particle engineering and nanotechnology company that provides novel API particle-size reduction services, is continuing its strategic growth through a significant €7 million investment, with Vator Securities acting as the …

19.09.2018 Nanoform set to transform drug development through €7 million investment in patented nanoparticle technologyRead More »